Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1996-10-22
|
pubmed:abstractText |
We determined the effect of intracerebroventricular (icv) administration of losartan, an angiotensin II (ANG II) subtype 1 receptor (AT1) antagonist, on icv carbachol-induced natriuresis, kaliuresis and antidiuresis in water-loaded male Holtzman rats (250-300 g) with a cannula implanted into the lateral ventricle (LV). The rats were water loaded with 5% of their body weight by gavage twice, with the second gavage one hour after the first. Carbachol (2 nmol in 1 microliter) was injected icv immediately after the second load. When losartan (DUP-753, 50 nmol in 1 microliter) was administered icv, it was given 3 min before carbachol. Previous icv treatment with losartan significantly reduced the icv carbachol-induced natriuresis (324 +/- 17 microEq/120 min), kaliuresis (103 +/- 15 microEq/120 min) and antidiuresis (13.5 +/- 2.1 ml/120 min) compared to the effects of previous icv injection of saline (Na+ excretion = 498 +/- 22 microEq/120 min; K+ excretion = 167 +/- 20 microEq/120 min; urine volume = 5.2 +/- 1.2 ml/120 min). These results, reported as means +/- SEM for 12 rats in each group, are consistent with the hypothesis that AT1 subtype receptors participate in the regulation of body electrolyte balance.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Biphenyl Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Carbachol,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0100-879X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
511-3
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:8736117-Angiotensin Receptor Antagonists,
pubmed-meshheading:8736117-Animals,
pubmed-meshheading:8736117-Biphenyl Compounds,
pubmed-meshheading:8736117-Carbachol,
pubmed-meshheading:8736117-Diuresis,
pubmed-meshheading:8736117-Drinking,
pubmed-meshheading:8736117-Imidazoles,
pubmed-meshheading:8736117-Injections, Intraventricular,
pubmed-meshheading:8736117-Losartan,
pubmed-meshheading:8736117-Male,
pubmed-meshheading:8736117-Natriuresis,
pubmed-meshheading:8736117-Potassium,
pubmed-meshheading:8736117-Rats,
pubmed-meshheading:8736117-Rats, Sprague-Dawley,
pubmed-meshheading:8736117-Tetrazoles
|
pubmed:year |
1996
|
pubmed:articleTitle |
Losartan (DUP-753) blocks the natriuretic, kaliuretic and antidiuretic effect of intracerebroventricular injection of carbachol in water-loaded rats.
|
pubmed:affiliation |
Departamento de Ciências Fisiológicas, Universidade Estadual Paulista, Araraquara, SP, Brasil.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|